New Humana Partnership Aims to Improve Preauthorization
Published:
October 30, 2020
New Humana partnership aims to improve preauthorization in 12 states
Humana is partnering with digital healthcare company Cohere Health to change the prior authorization process for musculoskeletal treatment in 12 states.
Musculoskeletal treatment affects bones, muscles, ligaments, tendons and nerves. Beginning Jan. 1, Humana will use Cohere’s technology to grant authorizations from initial diagnosis to treatment plan selection, or across the entire episode of care, for musculoskeletal conditions.
About 2 million members and 3,500-plus physicians will have access to the process.
The new musculoskeletal prior authorization process will be deployed in Alabama, Georgia, Indiana, Kentucky, Michigan, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia.
Written by
Cohere
Health
Cohere Health’s clinical intelligence platform delivers AI-powered solutions that streamline access to quality care by improving collaboration between physicians and health plans. Cohere works with 660,000 providers and processes millions of prior authorization requests annually. Its AI auto-approves up to 90% of requests for millions of health plan members. Cohere has been recognized in the Gartner® Hype Cycle™ for U.S. Healthcare Payers in 2024 and 2025, named a Top 5 LinkedIn™ Startup in 2023 and 2024, and is a three-time KLAS Points of Light award recipient.
Stay ahead with expert insights on transforming utilization management and payment integrity—delivered straight to your inbox.